A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR+CXCL-CXCR1/2 Pathway Inhibitor.
Grytsai O, Dufies M, Le Du J, Rastoin O, Pires Gonçalves LC, Mateo L, Lacas-Gervais S, Cao Y, Demange L, Pagès G, Benhida R, Ronco C.
Grytsai O, et al. Among authors: demange l.
ACS Med Chem Lett. 2024 Apr 3;15(6):845-856. doi: 10.1021/acsmedchemlett.4c00053. eCollection 2024 Jun 13.
ACS Med Chem Lett. 2024.
PMID: 38894897